Ultrafast CT developer Imatron of South San Francisco, CA, hasreceived a major cash infusion through a $9 million equity placementto a group of institutional investors based in Switzerland. Thevendor said the funds would be used to develop international
Ultrafast CT developer Imatron of South San Francisco, CA, hasreceived a major cash infusion through a $9 million equity placementto a group of institutional investors based in Switzerland. Thevendor said the funds would be used to develop international markets,establish a clinical research and customer demonstration facilityin the San Francisco area and support additional research andclinical applications for its technology.